MedTrace Logo

Lung Ultrasound for COVID-19 Initial Triage and Monitoring

NCT04474236 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2021-06-01

No results posted yet for this study

Summary

The QUICK study main aim is to assess the predictive value at Day 1, of a model built on lung ultrasound (LUS) and clinical data, both recorded at hospital admission of COVID-19 patients.

Conditions

  • COVID-19
  • Acute Respiratory Failure
  • Triage
  • Lung Ultrasound
  • CT Scan

Interventions

OTHER

thoracic lung ultrasound

Patients will be recruited the day of their hospital admission. All patients will be assessed by thoracic Computed Tomography scan then immediately before/after CT scan, patients will be clinically assessed (Q-SOFA, SpiO2/FiO2) and a lung ultrasound evaluation (mean time of evaluation 7 min +/- 3 min; fully respect of COVID-19 barrier measures) will be performed by an investigator. Patients clinical status and outcomes will be extracted from patient's medical file at day 1 and day 28 from patient's admission by investigators blinded from previously recorded lung ultrasound data.

Sponsors & Collaborators

  • University Hospital, Toulouse

    lead OTHER

Principal Investigators

  • Benjamine SARTON, ph · University Hospital, Toulouse

Eligibility

Min Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-27
Primary Completion
2021-03-07
Completion
2021-03-07

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04474236 on ClinicalTrials.gov